Pilot randomized controlled trial of an internet-based smoking cessation intervention for pregnant smokers (‘MumsQuit’)

Herbeć, Aleksandra; Brown, Jamie; Tombor, Ildikó; Michie, Susan; West, Robert A.

doi:10.1016/j.drugalcdep.2014.04.010

Cited by 29 publications

(58 citation statements)

References 42 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three studies used videotapes (Cinciripini et al, 2000;Price et al, 1991;Secker-Walker et al, 1997), and one study used telephone Interactive Voice Response Technology (IVR) (Ershoff et al, 1999). Two trials used websites, including a contingency management programme (Harris & Reynolds, 2015), and an interactive and personalised website, 'MumsQuit' (Herbec, Brown, Tombor, Michie, & West, 2014). The remaining two trials were computer programmes.…”

Section: Digital Interventionsmentioning

confidence: 99%

“…Five control arms used usual care, which was described as standard physician, obstetrician or nurse-midwife/midwife advice (Lawrence et al, 2003;Naughton et al, 2017;Ondersma et al, 2012;Price et al, 1991;Secker-Walker et al, 1997). Three trials used digitalised interventions as the comparator group: text-message comparison groups (Abroms et al, 2017;Pollak et al, 2013) and a static website providing brief smoking cessation advice (Herbec et al, 2014). One intervention used a nurse-led telephone counselling system (Harris & Reynolds, 2015).…”

Section: Comparator Groupsmentioning

confidence: 99%

“…An average of 77.6% of participants from 11 of the 12 included studies were of white ethnicity. Data regarding participants socio-economic status was varied, with only one study reporting socio-economic status (Herbec et al, 2014) and one reporting index of deprivation (Naughton et al, 2017). Ten studies reported the level of education; this ranged from 26.3% to 87% having less than a high-school education, and 30.2-49.8% having GCSEs/O-Level qualifications.…”

Section: Participant Detailsmentioning

confidence: 99%

See 2 more Smart Citations

Are digital interventions for smoking cessation in pregnancy effective? A systematic review and meta-analysis

Griffiths

Parsons

Naughton

et al. 2018

Health Psychology Review

Self Cite

View full text Add to dashboard Cite

Smoking in pregnancy remains a global public health issue due to foetal health risks and potential maternal complications. The aims of this systematic review and meta-analysis were to explore: (1) whether digital interventions for pregnancy smoking cessation are effective, (2) the impact of intervention platform on smoking cessation, (3) the associations between specific Behaviour Change Techniques (BCTs) delivered within interventions and smoking cessation and (4) the association between the total number of BCTs delivered and smoking cessation. Systematic searches of 9 databases resulted in the inclusion of 12 published articles (n = 2970). The primary meta-analysis produced a sample-weighted odds ratio (OR) of 1.44 (95% CI 1.04-2.00, p = .03) in favour of digital interventions compared with comparison groups. Computer-based (OR = 3.06, 95% CI 1.28-7.33) and text-message interventions (OR = 1.59, 95% CI 1.07-2.38) were the most effective digital platform. Moderator analyses revealed seven BCTs associated with smoking cessation: information about antecedents; action planning; problem solving; goal setting (behaviour); review behaviour goals; social support (unspecified); and pros and cons. A meta-regression suggested that interventions using larger numbers of BCTs produced the greatest effects. This paper highlights the potential for digital interventions to improve rates of smoking cessation in pregnancy.

show abstract

Section: Digital Interventionsmentioning

confidence: 99%

Section: Comparator Groupsmentioning

confidence: 99%

Section: Participant Detailsmentioning

confidence: 99%

See 1 more Smart Citation

Are digital interventions for smoking cessation in pregnancy effective? A systematic review and meta-analysis

Griffiths

Parsons

Naughton

et al. 2018

Health Psychology Review

Self Cite

View full text Add to dashboard Cite

show abstract

“…6,7 Others are based on financial incentives [8][9][10] and nicotine replacement therapy. [11][12][13] While some of these interventions have improved cessation during pregnancy, they lack effectiveness for the prevention of postpartum relapse.…”

Section: Introductionmentioning

confidence: 99%

Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial

Allen

Lunos

et al. 2016

NICTOB

View full text Add to dashboard Cite

Introduction: Pregnancy is a strong motivator to quit smoking, yet postpartum relapse rates are high. Growing evidence suggests a role of sex hormones in drug abuse behavior and given the precipitous drop in sex hormones at delivery, they may play a role in postpartum relapse. This pilot study evaluates the feasibility and potential role of exogenous progesterone in postpartum smoking relapse. Methods: This 12-week double-blind placebo-controlled randomized pilot trial randomized 46 abstinent postpartum women to active progesterone (PRO; 200 mg twice a day) versus placebo (PBO) for 4 weeks. Participants were followed for relapse for 12 weeks. Main study outcomes include abstinence (point prevalence), feasibility (compliance per number of clinic visits attended, pill counts and Electronic Data Capture [EDC] completed) and self-reported acceptability. Safety was also measured by depressive symptom scores, adverse events, and breastfeeding. Results: Overall retention rate was 87% at week 12. At week 4, abstinence rates were 75% in the PRO group and 68.2% in the PBO group (p = .75). Medication adherence was 68% and clinic visit attendance was 80%, with no differences by randomization. Depressive symptom scores, adverse events, and breastfeeding did not vary by randomization. Conclusions: Although the study was not powered to evaluate abstinence rates, we did observe a higher prevalence of abstinence at week 4 in the PRO group. Further, exogenous progesterone was well tolerated and did not adversely affect depressive symptoms or breastfeeding. Thus, the results of this pilot study indicate further investigation into progesterone as a postpartum relapse prevention strategy is warranted. Implications: This innovative pilot trial determined the feasibility of delivering exogenous progesterone as a potential prevention of postpartum smoking relapse. We observed high retention and moderate adherence rates, as well as high acceptability among participants. Further, though not statistically significant, more women in the treatment group remained abstinent from smoking during follow-up. This project adds to the growing body of literature on the role of sex hormones in smoking relapse and also provides support for a fully powered clinical trial.

show abstract

“…Only a few digital smoking cessation interventions have been designed specifically for pregnant smokers, but both Web sites and text-messaging programmes [15–18] have been found to be acceptable and potentially engaging in this population, and pilot comparative trials have shown positive but not statistically significant effects of these interventions [19–21]. However, to the best of our knowledge, no study has been published on the development or evaluation of smoking cessation apps for pregnant smokers.…”

Section: Introductionmentioning

confidence: 99%

Development of SmokeFree Baby: a smoking cessation smartphone app for pregnant smokers

Tombor

Shahab

Brown

et al. 2016

Behav. Med. Pract. Policy Res.

Self Cite

View full text Add to dashboard Cite

Pregnant smokers may benefit from digital smoking cessation interventions, but few have been designed for this population. The aim was to transparently report the development of a smartphone app designed to aid smoking cessation during pregnancy. The development of a smartphone app (‘SmokeFree Baby’) to help pregnant women stop smoking was guided by frameworks for developing complex interventions, including the Medical Research Council (MRC), Multiphase Optimization Strategy (MOST) and Behaviour Change Wheel (BCW). Two integrative behaviour change theories provided the theoretical base. Evidence from the scientific literature and behaviour change techniques (BCTs) from the BCT Taxonomy v1 informed the intervention content. The app was developed around five core modules, each with a distinct intervention target (identity change, stress management, health information, promoting use of face-to-face support and behavioural substitution) and available in a ‘control’ or ‘full’ version. SmokeFree Baby has been developed as part of a multiphase intervention optimization to identify the optimum combination of intervention components to include in smartphone apps to help pregnant smokers stop smoking.Electronic supplementary materialThe online version of this article (doi:10.1007/s13142-016-0438-0) contains supplementary material, which is available to authorized users.

show abstract

Pilot randomized controlled trial of an internet-based smoking cessation intervention for pregnant smokers (‘MumsQuit’)

Cited by 29 publications

References 42 publications

Are digital interventions for smoking cessation in pregnancy effective? A systematic review and meta-analysis

Are digital interventions for smoking cessation in pregnancy effective? A systematic review and meta-analysis

Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial

Development of SmokeFree Baby: a smoking cessation smartphone app for pregnant smokers

Contact Info

Product

Resources

About